Biosimilars can improve access to treatment for patients who might not have been able to access biologics previously, explained Laura Wingate, executive vice president, Education, Support, & Advocacy, Crohn's & Colitis Foundation.

Related Keywords

United States , Laura Wingate , Crohn Colitis Foundation , Biosimilars , Access , Cost ,